Literature DB >> 24977652

Botulinum neurotoxin-A in idiopathic chondrolysis: a report of two cases.

Khalid I Khoshhal1, Yasser Awaad, Alshahid A Abbak.   

Abstract

Two cases of idiopathic chondrolysis were treated by botulinum neurotoxin-A injections, with a favorable outcome. The treatment consisted of botulinum neurotoxin-A injections, followed by an intensive rehabilitation program. No surgery was needed. Both patients were symptom-free and showed an extremely satisfactory range of motion. Radiographs indicated reconstitution of the joint space in both cases. We believe that botulinum neurotoxin-A injections combined with an intensive rehabilitation program may be considered a new potential management modality and is worth attempting and studying when one considers the results of previously published reports.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24977652     DOI: 10.1097/BPB.0000000000000076

Source DB:  PubMed          Journal:  J Pediatr Orthop B        ISSN: 1060-152X            Impact factor:   1.041


  2 in total

Review 1.  Idiopathic hip chondrolysis: a case report of a Caucasian HLA-B27 positive adolescent with a history of long walking.

Authors:  Khaled T Kampani; Dimitrios V Papadopoulos; Andreas G Tsantes; Anna Batistatou; Aristotelis Fylaktos; Christos D Papageorgiou
Journal:  Rheumatol Int       Date:  2019-01-05       Impact factor: 2.631

Review 2.  MRI Features and Treatment for Idiopathic Chondrolysis of the Hip (ICH) in Children: Outcomes of a Systematic Review.

Authors:  Sandeep Kumar Nema; Premkumar Ramasubramani; Jose Austine; Govind Karunakaran; Vendoti Nitheesha Reddy; Vendoti Midhusha Reddy
Journal:  Indian J Orthop       Date:  2022-07-02       Impact factor: 1.033

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.